Exciting results for frontline ibrutinib plus FCR for younger CLL patients

There are now many effective therapies to choose from for chronic lymphocytic leukemia (CLL). Thus, a recent area of therapeutic development in CLL is the creation of time-limited regimens and curativ... Author: VJHemOnc Added: 01/11/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts